InVivoMab anti-mouse TIGIT

Catalog number: BE0274_100mg
Brand: Bio X Cell
Packing: 100 mg
Other sizes: Other sizes available
Price: € 2715.00
Expected delivery time: 7 days
Quantity:

Product specifications for - InVivoMab anti-mouse TIGIT

Promotion: 
Promotion: The price displayed is only for academic or non-profit organizations. Please contact our helpdesk for regular prices.
Overview: 
Product group: Antibodies
Category: Primary Antibodies
Application: Flow Cytometry; Other Application
Species: Mouse
Host: Mouse
Clonality: Monoclonal
Isotype: IgG1 Kappa
Properties: 
Molecular weight: 150 kDa
Datasheet: Datasheet
  Research Use Only
UNSPSC: 12352203
Concentration: 2-10 mg/ml
Scientific information: 
Clone ID: 1G9
Related products: 
Related products: Recommended Isotype Control(s): InVivoMab mouse IgG1 isotype control (BE0083)
Recommended Dilution Buffer: InVivoPure pH 7.0 Dilution Buffer (IP0070)
Additional information: 
Synonyms: 1G9; BE0274; BioXCell
Tršan T, Vuković K, Filipović P, et al. Cytomegalovirus vector expressing RAE-1γ induces enhanced anti-tumor capacity of murine CD8 T cells. Eur J Immunol. 2017;47(8):1354-1367. Read more
Kourepini E, Paschalidis N, Simoes DC, Aggelakopoulou M, Grogan JL, Panoutsakopoulou V. TIGIT Enhances Antigen-Specific Th2 Recall Responses and Allergic Disease. J Immunol. 2016;196(9):3570-80. Read more
Burton BR, Britton GJ, Fang H, et al. Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy. Nat Commun. 2014;5:4741. Read more
Chan CJ, Martinet L, Gilfillan S, et al. The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions. Nat Immunol. 2014;15(5):431-8. Read more
Foks AC, Ran IA, Frodermann V, et al. Agonistic anti-TIGIT treatment inhibits T cell responses in LDLr deficient mice without affecting atherosclerotic lesion development. PLoS ONE. 2013;8(12):e83134. Read more
Joller N, Hafler JP, Brynedal B, et al. Cutting edge: TIGIT has T cell-intrinsic inhibitory functions. J Immunol. 2011;186(3):1338-42. Read more